|
"Clinical trials are an important part of the research spectrum. The idea for a clinical trial often starts in the lab..."
“Pazopanib could be considered in patients with von Hippel-Lindau disease and growing lesions who might require surgical resection in the near future, or to reduce tumor size in patients with unresectable lesions…” Also "shows promise in rare cancer syndrome..." "encouraging preliminary activity..." Comments are closed.
|
|
VHL Canada is a small registered charitable organization* started by a patient in 2016 that facilitates peer support with patients and their family members coping with VHL in Canada
